United States · FDA National Drug Code directory
Pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-871_1815296c-fc89-41c8-9079-ffb947b59b0f
- Product NDC
- 71205-871
- Form
- CAPSULE
- Composition / generic term
- Pregabalin
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210824
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (71205-871-00) · 71205-871-00
- 1000 CAPSULE in 1 BOTTLE (71205-871-11) · 71205-871-11
- 30 CAPSULE in 1 BOTTLE (71205-871-30) · 71205-871-30
- 500 CAPSULE in 1 BOTTLE (71205-871-55) · 71205-871-55
- 60 CAPSULE in 1 BOTTLE (71205-871-60) · 71205-871-60
- 270 CAPSULE in 1 BOTTLE (71205-871-67) · 71205-871-67
- 120 CAPSULE in 1 BOTTLE (71205-871-72) · 71205-871-72
- 180 CAPSULE in 1 BOTTLE (71205-871-78) · 71205-871-78
- 90 CAPSULE in 1 BOTTLE (71205-871-90) · 71205-871-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →